Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-042095
Filing Date
2021-10-29
Accepted
2021-10-29 19:33:19
Documents
1
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3861
  Complete submission text file 0000899243-21-042095.txt   5241
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ZENTALIS PHARMACEUTICALS, LLC 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Johnson David Michael (Reporting) CIK: 0001808098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 211364851